Article
Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
1 Mar 2023
Abstract excerpt
BACKGROUND: Cell-free DNA (cfDNA) is being explored as biomarker for non-invasive diagnosis of cancer. We aimed to establish a cfDNA-based DNA methylation marker panel to differentially diagnose papillary thyroid carcinoma (PTC) from benign thyroid nodule (BTN). METHODS: 220 PTC- and 188 BTN patients were enrolled. Methylation markers of PTC were identified from patients' tissue and plasma by reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
